Sosler S D, Behzad O, Garratty G, Lee C L, Postaway N, Khomo O
Transfusion. 1984 May-Jun;24(3):206-9. doi: 10.1046/j.1537-2995.1984.24384225022.x.
A patient with acute hemolytic anemia and a positive direct antiglobulin test was found to be Jk(a + b +) with anti-Jka in her serum. For 2 weeks prior to admission, the patient had taken chlorpropamide, a hypoglycemic agent. The drug was discontinued upon the diagnosis of hemolytic anemia, and the hemoglobin concentration gradually increased. When chlorpropamide was added to the patient's serum in vitro, it enhanced the reactivity of the anti-Jka, and 40 days posttransfusion, the serum would only react with Jk(a+) red cells when chlorpropamide was present. These findings suggest that a chlorpropamide-dependent antibody with Jka specificity had formed. We do not know why the antibody induced by chlorpropamide reacted preferentially with Jk(a+) red cells.
一名患有急性溶血性贫血且直接抗球蛋白试验呈阳性的患者,其血清中被检测出Jk(a + b +)以及抗Jka。在入院前2周,该患者服用了降糖药氯磺丙脲。在溶血性贫血被诊断出来后,该药物被停用,血红蛋白浓度逐渐上升。当在体外将氯磺丙脲添加到患者血清中时,它增强了抗Jka的反应性,并且在输血后40天,只有当存在氯磺丙脲时血清才会与Jk(a+)红细胞发生反应。这些发现表明已经形成了一种具有Jka特异性的氯磺丙脲依赖性抗体。我们不知道为什么氯磺丙脲诱导产生的抗体优先与Jk(a+)红细胞发生反应。